Literature DB >> 8891861

Pathophysiologic and therapeutic implications of sleep apnea in congestive heart failure.

T D Bradley1, J S Floras.   

Abstract

Obstructive and central sleep apnea are common in patients with congestive heart failure (CHF). These sleep-related breathing disorders are characterized by two pathophysiologic features that could have important implications for disease progression in CHF: sympathetic nervous system activation, and adverse changes in cardiac loading conditions. In patients with obstructive sleep apnea, blood pressure is frequently elevated as a result of excessive sympathetic nervous system activity elicited by the combination of apnea, hypoxia, and arousals from sleep. The generation of exaggerated negative intrathoracic pressure during obstructive apneas further increases left ventricular afterload, reduces cardiac output, and may promote the progression of pump failure. Increased afterload and hypoxia can also predispose such patients to myocardial ischemia and arrhythmias. In patients with CHF, abolition of coexisting obstructive sleep apnea by nasal continuous positive airway pressure improves left ventricular function. Central sleep apnea (i.e., Cheyne-Stokes respiration) is also characterized by apnea, hypoxia, and increased sympathetic nervous system activity and, when present in CHF, is associated with increased risk of death. Recent medium-term trials involving small numbers of patients have demonstrated that nocturnally applied continuous positive airway pressure in patients with CHF and central sleep apnea alleviates central sleep apnea, improves left ventricular function, reduces sympathetic nervous system activity and improves symptoms of CHF. These studies emphasize the importance of considering obstructive and central sleep apnea in the differential diagnosis of conditions that could contribute to the development or progression of CHF. They also suggest that continuous positive airway pressure is a promising nonpharmacologic adjunctive therapy for patients with CHF and coexisting sleep-related breathing disturbances that warrants further investigation.

Entities:  

Mesh:

Year:  1996        PMID: 8891861     DOI: 10.1016/s1071-9164(96)80045-5

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  13 in total

Review 1.  Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome.

Authors:  P Gordon; M H Sanders
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

2.  Sleep apnoea in ischaemic heart disease: differences between acute and chronic coronary syndromes.

Authors:  P Moruzzi; S Sarzi-Braga; M Rossi; M Contini
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

Review 3.  Impact of Obstructive Sleep Apnea on Outcomes of Catheter Ablation of Atrial Fibrillation.

Authors:  Jane Dewire; Hugh Calkins
Journal:  J Atr Fibrillation       Date:  2013-02-12

4.  Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: importance of underlying cardiac rhythm.

Authors:  J L Kiely; P Deegan; A Buckley; P Shiels; B Maurer; W T McNicholas
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

5.  Left ventricular dysfunction, pulmonary hypertension, obesity, and sleep apnea.

Authors:  R P Blankfield; A A Tapolyai; S J Zyzanski
Journal:  Sleep Breath       Date:  2001-06       Impact factor: 2.816

6.  Sleep-Breathing Disorders and Heart Failure.

Authors:  Stefan Thalhofer; Peter Dorow
Journal:  Sleep Breath       Date:  2000       Impact factor: 2.816

7.  Treatment of sleep apnea in congestive heart failure with a dental device: the effect on brain natriuretic peptide and quality of life.

Authors:  Mahmoud Eskafi; Charles Cline; Maria Nilner; Bo Israelsson
Journal:  Sleep Breath       Date:  2006-06       Impact factor: 2.816

8.  The prevalence and significance of periodic leg movements during sleep in patients with congestive heart failure.

Authors:  Robert Skomro; Rogerio Silva; Rosana Alves; Adelaide Figueiredo; Geraldo Lorenzi-Filho
Journal:  Sleep Breath       Date:  2008-07-01       Impact factor: 2.816

9.  Effects of obstructive sleep apnea on autonomic cardiac control during sleep.

Authors:  Sérgio P da Silva; Verne D Hulce; Richard W Backs
Journal:  Sleep Breath       Date:  2008-10-24       Impact factor: 2.816

Review 10.  Contribution of peripheral and central chemoreceptors to sympatho-excitation in heart failure.

Authors:  Camilo Toledo; David C Andrade; Claudia Lucero; Harold D Schultz; Noah Marcus; Mauricio Retamal; Carlos Madrid; Rodrigo Del Rio
Journal:  J Physiol       Date:  2016-06-19       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.